Company intelligence / Profile preview

M Ventures

Ownership: Private
Employees: ~29
Development stage: Other

Overview

M Ventures is the strategic corporate venture capital fund of Merck KGaA, Darmstadt, Germany. It invests globally in early-stage and growth-stage biotechnology and technology startups with a dual mandate for strategic alignment with Merck’s business interests and financial returns. Its healthcare/life science investments span drug development platforms/tools as well as therapeutics targeting oncology and immunology among other areas. The fund takes an active role in supporting entrepreneurs toward commercial success.

Therapeutic areas: OncologyImmunology
Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugateCell therapyGene therapy
Industry: Investors

Partnerships

Collaborates closely with co-investors including major pharma/biotech VCssome investee companies have partnerships with large pharmas including Merck KGaA

Beyond the preview

Go deeper on M Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on M Ventures.

Explore the full profile